Apria Healthcare Llc Durable Medical Equipment & Medical Supplies Location: 325a Inglesby Pkwy, Duncan, South Carolina 29334 Phone: (864) 433-0615 |
Bioscrip Infusion Services Medicare Supplier Location: 160 Congress Blvd, Duncan, South Carolina 29334 Phone: (864) 583-8190 |
Ingles Markets Pharmacy 93 Community/Retail Pharmacy Location: 2150 E Main St, Duncan, South Carolina 29334 Phone: (864) 433-0422 |
Publix Pharmacy #0543 Durable Medical Equipment & Medical Supplies Location: 2153 E Main St, Duncan, South Carolina 29334 Phone: (864) 486-4706 |
Resource Medical Group Llc Medicare Supplier Location: 110a Aztec Ct, Duncan, South Carolina 29334 Phone: (864) 968-2022 |
Walgreens #12447 Durable Medical Equipment & Medical Supplies Location: 2196 E Main St, Duncan, South Carolina 29334 Phone: (864) 486-1779 |
News Archive
CEL-SCI Corporation announced today that it has received approval to begin enrollment of patients in its Phase III clinical trial of Multikine® from the Polish Minister of Health. This approval marks a very important milestone, namely that all nine countries in the study have now given official government approval. Five of about 48 clinical centers for this global trial will be located in Poland.
Citing what he called fetal pain, former GOP presidential hopeful Rick Perry urged state lawmakers to ban abortions after 20 weeks of pregnancy. He said his ultimate goal was to eliminate abortions altogether.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that it has received a contract for approximately $1.3 million from an undisclosed international customer to deliver its DTX-200 DexaCare® bone densitometers.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables the company's clients to assess treatment opportunities and guide commercial decisions in the $48 billion global oncology market.
› Verified 3 days ago